₹28.92
▼ -0.31 -1.06%
17 Jul 2026
BSE Listed
GSM 0 · ESM 1Prism Medico And Pharmacy (512217)
Volume: 1,360Avg Vol 1W: 1,717Avg Vol 1M: 5,32952W Range:₹12.49₹34.49
Key Ratios
Checked 7h agoMarket Cap₹40 Cr
Current Price₹28.92
Previous Close₹29.23
High / Low (52w)₹34.49 / ₹12.49
Volume1,360
Avg Vol (1W)1,717
Avg Vol (1M)5,329
Stock P/E127.04
Book Value₹16.89
Dividend Yield0%
ROE206.6%
ROA211.4%
Revenue (TTM)—
Revenue Growth—
Profit Margin13.52%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹0.23
P/B1.73
Debt / Equity0.17
50 DMA₹28.83
200 DMA₹23.55
Day change-1.06%
SurveillanceGSM 0 · ESM 1 (as of 2026-07-17)
Price Chart
₹28.92▲ 103.95% · 1Y
2025-07-172026-07-17
20-day avg volume: 4K shares
Pros
- Healthy return on equity of 206.6%.
- Company is almost debt-free.
- Revenue grew 140% YoY.
Cons
- Stock trades at a high P/E of 127.
Quarterly Results
| Metric | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹0 Cr | ₹6 Cr | ₹15 Cr | ₹17 Cr | ₹17 Cr | ₹9 Cr | ₹7 Cr | ₹10 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2017 | Mar 2018 | Mar 2019 |
|---|---|---|---|
| Revenue | ₹5 Cr | ₹23 Cr | ₹55 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EPS | -0.36 | -0.01 | 0.07 |
Balance Sheet
| Metric | Mar 2017 | Mar 2018 | Mar 2019 |
|---|---|---|---|
| Total Assets | ₹17 Cr | ₹16 Cr | ₹21 Cr |
| Total Liabilities | ₹4 Cr | ₹3 Cr | ₹8 Cr |
| Equity | ₹13 Cr | ₹13 Cr | ₹13 Cr |
| Total Debt | — | — | — |
Cash Flow
| Metric | Mar 2018 | Mar 2019 |
|---|---|---|
| Operating | ₹4 Cr | ₹0 Cr |
| Investing | ₹-3 Cr | ₹0 Cr |
| Financing | ₹-2 Cr | ₹-1 Cr |
| Free Cash Flow | ₹4 Cr | ₹0 Cr |
Shareholding
Promoter 30.2% Institutions 0% Public 69.8%
Efficiency & Working Capital
ROCE2.8%
Interest Coverage2.2
Dividend Payout—
Debtor Days21 d
Inventory Days9 d
Payable Days39 d
Cash Conversion Cycle-8 d
Working Capital Days30 d
Shareholding Details
As of 2026-05-31
Promoter30.2%
FII0%
DII0%
Institutions0%
Public69.8%
Promoter Pledge0%
No. of Shareholders4,300
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | May 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 25.5% | 30.2% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 74.5% | 69.8% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 3,465 | 3,650 | 3,792 | 3,866 | 4,107 | 4,178 | 4,302 | 4,306 | 4,315 | 4,306 | 4,295 | 4,300 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Dharmender Kharb | Public Shareholding | 19.4% | 26,25,000 |
| Symbiosis Pharmaceutical Private Limited | Shareholding of Promoter and Promoter Group | 15.7% | 21,23,083 |
| Galaxy Vitacare Private Limited | Shareholding of Promoter and Promoter Group | 13.3% | 17,97,672 |
| Raju Tyagi | Public Shareholding | 9.8% | 13,25,000 |
| Sejal S Nashatar | Public Shareholding | 2.5% | 3,40,000 |
| Harsh Jentibhai Rupareliya | Public Shareholding | 2.4% | 3,30,000 |
| Shilpa Harsh Rupareliya | Public Shareholding | 2.4% | 3,30,000 |
| Bosco Armando Menezes | Public Shareholding | 1.1% | 1,50,000 |
| Emily Bosco Menezes | Public Shareholding | 1.1% | 1,50,000 |
| Ramit Walia | Shareholding of Promoter and Promoter Group | 1.1% | 1,45,106 |
| Reeta Devi | Public Shareholding | 1% | 1,39,740 |
| Jasjot Singh | Shareholding of Promoter and Promoter Group | 0.2% | 30,000 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Ramit Walia | 0 | 0% | 2026-05-05 |
| Jasjot Singh | 0 | 0% | 2026-05-05 |
| Symbiosis Pharmaceutical Private Limited | 0 | 0% | 2026-05-05 |
| Galaxy Vitacare Private Limited | 0 | 0% | 2026-05-05 |
| Bosco Armando Menezes | 0 | 0% | 2026-05-05 |
| Reeta Devi | 0 | 0% | 2026-05-05 |
| Emily Bosco Menezes | 0 | 0% | 2026-05-05 |
| Sejal S Nashatar | 0 | 0% | 2026-05-05 |
| Harsh Jentibhai Rupareliya | 0 | 0% | 2026-05-05 |
| Shilpa Harsh Rupareliya | 0 | 0% | 2026-05-05 |
| Raju Tyagi | 0 | 0% | 2026-05-05 |
| Dharmender Kharb | 0 | 0% | 2026-05-05 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Sakshi Laller | Whole-time Director | 2025 |
| Davender Singh | Director | 2025 |
| DINESH KUMAR | Independent Non Exe. Director | 2025 |
| Pradeep Kumar | Independent Non Exe. Director | 2025 |
| Sameer Gupta | Company Sec. & Compli. Officer | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 25 | 6 | 6 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 0 | 3 | — |
| 2025 | 0 | 0 | 0 | 0 | 1 | 1 |
| 2025 | 0 | 0 | 0 | 0 | 1 | 1 |
Substantial Acquisitions (SAST)
6 disclosure(s)
Market18/08/2021 · 22,165
Market12/08/2021 · 11,320
Market06/08/2021 · 25,000
Market26/07/2021 - 27/07/2021 · 65,000
Market23/07/2021 · 2,500
Market22/07/2021 · 85,000
Company Information
🌐 www.prismmedico.in ↗
📍 D-118 Industrial Area, Phase VII, Mohali, Punjab, 160055
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search